{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:09:20Z","timestamp":1790208560430,"version":"4.1.0"},"reference-count":70,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Pearl M. Stetler Fund Research Award","award":["2019"],"award-info":[{"award-number":["2019"]}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI137720"],"award-info":[{"award-number":["R21 AI137720"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI155664"],"award-info":[{"award-number":["R01 AI155664"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,3,18]]},"abstract":"<jats:p>\n            <jats:named-content content-type=\"genus-species\">Mycobacteroides abscessus<\/jats:named-content>\n            (\n            <jats:italic>Mab<\/jats:italic>\n            ) is an opportunistic environmental pathogen that can cause chronic pulmonary disease in the setting of structural lung conditions such as bronchiectasis, chronic obstructive pulmonary disease, and cystic fibrosis. These infections are often incurable and associated with rapid lung function decline.\n            <jats:italic>Mab<\/jats:italic>\n            is naturally resistant to most of the antibiotics available today, and current treatment guidelines require at least 1 year of daily multidrug therapy, which is often ineffective and is associated with significant toxicities. \u03b2-Lactams are the most widely used class of antibiotics and have a demonstrated record of safety and tolerability.\n          <\/jats:p>","DOI":"10.1128\/aac.02545-20","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T13:42:06Z","timestamp":1615988526000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":30,"title":["\u03b2-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates"],"prefix":"10.1128","volume":"65","author":[{"given":"Elizabeth","family":"Story-Roller","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Galanis","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2214-0114","authenticated-orcid":true,"given":"Gyanu","family":"Lamichhane","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.1.15"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.4187\/aarc0427"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-14-130"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201609-668OC"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2303.161827"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hct022"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00067"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2009.12.001"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000104"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq237"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.04.166"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.15.4.716-746.2002"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr578"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2012.04.001"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7030090"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(16)00018-7"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks279"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.36.1.180"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.3.500"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207360"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210927"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200905-0704OC"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12405"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3267"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/235426a0"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/9781555819316","volume-title":"Antibiotics: challenges, mechanisms, opportunities","author":"Walsh C","year":"2016","unstructured":"Walsh C, Wencewicz TA. 2016. Antibiotics: challenges, mechanisms, opportunities, p 37\u201368. American Society for Microbiology, Washington, DC."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00606-10"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2016-0208"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00665-12"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00866-17"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2237"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2120"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02613-18"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02895-18"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00614-19"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063237"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep04061"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0331-1"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1953.18"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0286"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01688-08"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-879"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2010.00221.x"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa055"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.33.12.2037"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(93)90087-n"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301"},{"key":"e_1_3_3_50_2","volume-title":"Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. Supplement M62. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186793"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57844-8"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01663-13"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/BR.38.3.291-335.1974"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.11.2814"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M507384200"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0196-0709(80)80012-3"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.45.9.2502-2509.2001"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e32833eebfd"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24631"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00425-19"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262150-00005"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60452-1"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01158-15"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01035-15"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx152"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.3967\/bes2019.033"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02282-15"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/AM.26.5.658-665.1973"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.2.462"},{"key":"e_1_3_3_71_2","first-page":"313","volume-title":"Molecular genetics of mycobacteria","author":"Larsen M","year":"2000","unstructured":"Larsen M. 2000. Some common methods in mycobacterial genetics, p 313\u2013320. In Hatfull GF, Jacobs WRJ (ed), Molecular genetics of mycobacteria. American Society for Microbiology, Washington, DC."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02545-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02545-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:40:11Z","timestamp":1645486811000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02545-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3,18]]}},"alternative-id":["10.1128\/AAC.02545-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.02545-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"2020-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02545-20"}}